PLANTA MEDICA

metrics 2024

Illuminating the Path to Herbal Innovation

Introduction

PLANTA MEDICA is a premier journal dedicated to advancing the field of medicinal plant research, published by Georg Thieme Verlag KG in Germany. With an ISSN of 0032-0943 and an E-ISSN of 1439-0221, this journal has been a cornerstone of scholarly communication since its inception in 1961. Recognized for its rigorous peer-review process, PLANTA MEDICA holds a notable reputation in the academic landscape, featuring a 2023 Q2 ranking in categories such as Analytical Chemistry and Pharmaceutical Science, along with respectable Q3 rankings in Drug Discovery and Molecular Medicine. The journal focuses on the synthesis, pharmacological, and biochemical assessment of phytochemicals, making it an essential resource for researchers, professionals, and students alike who are engaged in the exploration of complementary and alternative medicine. Although it does not offer open access options, its content is instrumental in identifying new therapeutic agents derived from plants, thereby underscoring its importance in drug discovery and holistic health research.

Metrics 2024

SCIMAGO Journal Rank0.45
Journal Impact Factor2.10
Journal Impact Factor (5 years)2.80
H-Index135
Journal IF Without Self2.10
Eigen Factor0.00
Normal Eigen Factor0.53
Influence0.43
Immediacy Index0.50
Cited Half Life15.10
Citing Half Life7.80
JCI0.59
Total Documents5285
WOS Total Citations13284
SCIMAGO Total Citations37153
SCIMAGO SELF Citations2230
Scopus Journal Rank0.45
Cites / Document (2 Years)2.07
Cites / Document (3 Years)2.43
Cites / Document (4 Years)2.74

Metrics History

Rank 2024

Scopus

Complementary and Alternative Medicine in Medicine
Rank #24/105
Percentile 77.14
Quartile Q1
Pharmaceutical Science in Pharmacology, Toxicology and Pharmaceutics
Rank #70/183
Percentile 61.75
Quartile Q2
Analytical Chemistry in Chemistry
Rank #62/156
Percentile 60.26
Quartile Q2
Organic Chemistry in Chemistry
Rank #86/211
Percentile 59.24
Quartile Q2
Pharmacology in Pharmacology, Toxicology and Pharmaceutics
Rank #152/313
Percentile 51.44
Quartile Q2
Drug Discovery in Pharmacology, Toxicology and Pharmaceutics
Rank #80/157
Percentile 49.04
Quartile Q3
Molecular Medicine in Biochemistry, Genetics and Molecular Biology
Rank #106/178
Percentile 40.45
Quartile Q3

IF (Web Of Science)

CHEMISTRY, MEDICINAL
Rank 51/72
Percentile 29.90
Quartile Q3
INTEGRATIVE & COMPLEMENTARY MEDICINE
Rank 20/43
Percentile 54.70
Quartile Q2
PHARMACOLOGY & PHARMACY
Rank 210/354
Percentile 40.80
Quartile Q3
PLANT SCIENCES
Rank 109/265
Percentile 59.10
Quartile Q2

JCI (Web Of Science)

CHEMISTRY, MEDICINAL
Rank 46/72
Percentile 36.11
Quartile Q3
INTEGRATIVE & COMPLEMENTARY MEDICINE
Rank 23/43
Percentile 46.51
Quartile Q3
PHARMACOLOGY & PHARMACY
Rank 203/354
Percentile 42.66
Quartile Q3
PLANT SCIENCES
Rank 110/265
Percentile 58.49
Quartile Q2

Quartile History

Similar Journals

Frontiers in Pharmacology

Fostering collaboration and innovation in pharmaceutical sciences.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.

PHYTOCHEMICAL ANALYSIS

Illuminating the Path of Phytochemical Exploration
Publisher: WILEYISSN: 0958-0344Frequency: 8 issues/year

PHYTOCHEMICAL ANALYSIS is a renowned journal published by WILEY that serves as a vital resource in the fields of analytical chemistry, biochemistry, and plant sciences, among others. With an ISSN of 0958-0344 and an E-ISSN of 1099-1565, this journal has been at the forefront of phytochemical research since its inception in 1990, with a commitment to advancing knowledge up to 2024. Notably, it boasts impressive Scopus rankings, including a Q1 quartile in Complementary and Alternative Medicine, highlighting its significant impact in this area. The journal provides essential insights into phytochemical analysis for a diverse audience that includes researchers, industry professionals, and students, thereby facilitating the discovery and application of phytochemicals in various fields such as drug discovery and food science. The journal is not currently open access, yet it remains a pivotal platform for disseminating high-quality research findings. With its focus on interdisciplinary approaches and innovative methodologies, PHYTOCHEMICAL ANALYSIS continues to reinforce its reputation as a cornerstone of contemporary research in plant science and related disciplines.

Annals of Phytomedicine-An International Journal

Connecting Research and Practice in Phytomedicine
Publisher: UKAAZ PUBLICATIONSISSN: 2393-9885Frequency: 2 issues/year

Annals of Phytomedicine - An International Journal is a leading publication dedicated to the exploration and advancement of phytomedicine, broadly encompassing research on medicinal plants, their bioactive compounds, and therapeutic applications. Published by UKAAZ Publications, this journal seeks to bridge the gap between traditional and modern medicinal practices, offering a platform for researchers, professionals, and students passionate about herbal therapies and their efficacy. With an ISSN 2393-9885 and E-ISSN 2278-9839, the journal adheres to stringent peer-review protocols to ensure the publication of high-quality research. Fostering open access to knowledge in a rapidly evolving field, Annals of Phytomedicine serves as an essential resource, promoting innovative findings and comprehensive reviews that drive the global discourse on phytotherapy. By engaging with this journal, readers can stay informed about the latest advancements, contributing significantly to the scholarly community and beyond.

Journal of Pharmacy & Pharmacognosy Research

Elevating Standards in Pharmaceutical Science
Publisher: JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRESISSN: 0719-4250Frequency: 6 issues/year

Journal of Pharmacy & Pharmacognosy Research, published by JOURNAL PHARMACY & PHARMACOGNOSY RESEARCH-JPPRES, is a prominent open-access journal established in 2013, headquartered in Antofagasta, Chile. With a focus on the fields of Complementary and Alternative Medicine, Drug Discovery, Pharmaceutical Science, Pharmacology, and Pharmacy, this journal is recognized for its commitment to advancing research and disseminating knowledge within these important areas. With a current impact factor that reflects its academic rigor and relevance, the journal has achieved substantial recognition, evident by its Q2 and Q3 quartile rankings in multiple categories, indicating its growing influence on the scientific community. The Scopus rankings further highlight its standing in pharmacy and pharmacological disciplines, providing a valuable platform for researchers, professionals, and students to share their findings and insights. With its open access model, the journal ensures that high-quality research is available to a global audience, paving the way for collaborative advancements in pharmaceutical sciences.

Pakistan Journal of Pharmaceutical Sciences

Delivering critical studies that shape the pharmaceutical landscape.
Publisher: UNIV KARACHIISSN: 1011-601XFrequency: 4 issues/year

Pakistan Journal of Pharmaceutical Sciences, published by the University of Karachi, serves as a vital platform for advancing research in the field of pharmaceutical sciences. With a strong commitment to disseminating innovative findings and critical studies since its inception in 1995, the journal focuses on a wide array of topics including pharmacology, toxicology, and pharmaceutics. With an ISSN of 1011-601X, it holds a reputable position within the academic community, reflecting its Q3 category ranking in Pharmaceutical Science as of 2023. While the journal is currently not designated as Open Access, it remains accessible through institutional subscriptions, ensuring that both emerging and established researchers can contribute to and benefit from its scholarly content. This publication not only promotes scientific dialogue but also aims to bridge the gap between academia and industry, appealing to a diverse audience of researchers, professionals, and students seeking to stay informed about the latest advancements and trends in pharmaceutical research.

BIOORGANIC & MEDICINAL CHEMISTRY

Innovating Drug Discovery Through Chemistry
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0968-0896Frequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

CURRENT TOPICS IN MEDICINAL CHEMISTRY

Leading the Way in Medicinal Chemistry Research
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1568-0266Frequency: 32 issues/year

CURRENT TOPICS IN MEDICINAL CHEMISTRY is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of medicinal chemistry through the dissemination of high-quality research from 2001 to 2024. With an ISSN of 1568-0266 and an E-ISSN of 1873-4294, this journal is recognized for its significant contributions, as evidenced by its Scopus ranking in the 63rd percentile in the category of Drug Discovery, specifically at position #58 out of 157. Currently placed in Quartile 3 within Drug Discovery and Quartile 2 in miscellaneous medicine as of 2023, it serves as an essential resource for researchers, professionals, and students interested in the latest developments, methodologies, and applications in medicinal chemistry. The journal aims to foster collaboration and innovation by featuring original research articles, reviews, and brief communications that address current and emerging challenges in the discipline. Although it is not an open access platform, the journal's rich content is indispensable for those striving to enhance therapeutic strategies and drug development processes.

PHARMACEUTICAL BIOLOGY

Pioneering Research at the Intersection of Biology and Pharmacy
Publisher: TAYLOR & FRANCIS LTDISSN: 1388-0209Frequency: 1 issue/year

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

CURRENT MEDICINAL CHEMISTRY

Unveiling the Science Behind Effective Therapies.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 0929-8673Frequency: 42 issues/year

Current Medicinal Chemistry is a leading journal published by Bentham Science Publishers Ltd, known for its rigorous focus on the multifaceted realm of medicinal chemistry. With an ISSN of 0929-8673 and E-ISSN 1875-533X, the journal plays a crucial role in disseminating high-quality research findings that bridge the gap between chemistry and health sciences. Operating from Sharjah, United Arab Emirates, it has been a prominent scholarly resource since its inception in 1994, and is expected to continue until 2024. Current Medicinal Chemistry has earned its place in the academic community with an impressive impact factor and categorization in Q1 and Q2 quartiles across various disciplines, including Organic Chemistry, Biochemistry, Drug Discovery, and Pharmacology, highlighting its substantial contribution to these fields. Notably, it ranks 24th in Organic Chemistry and is within the 88th percentile, underscoring its appeal to researchers, professionals, and students alike who are keen on exploring cutting-edge advancements in drug design and development. Although it is not an open-access journal, it provides vital content that informs and inspires innovation in medicinal chemistry, appealing to a global audience committed to enhancing human health through scientific discovery.

Avicenna Journal of Phytomedicine

Harnessing the Power of Medicinal Plants
Publisher: MASHHAD UNIV MED SCIENCESISSN: 2228-7930Frequency: 6 issues/year

Avicenna Journal of Phytomedicine, published by Mashhad University of Medical Sciences, is a premier Open Access journal dedicated to advancing the field of phytomedicine. Established in 2011, this journal aims to promote research on the therapeutic potentials of medicinal plants, integrating traditional knowledge with modern pharmacological insights. With an ISSN of 2228-7930 and an E-ISSN of 2228-7949, it has garnered significant attention in the research community, achieving a Q2 ranking in Complementary and Alternative Medicine and a Q3 ranking in Drug Discovery as of 2023. Its Scopus rankings affirm the journal's relevance, with the journal positioned at 37 out of 105 in its category, reflecting a 65th percentile. The Avicenna Journal of Phytomedicine serves as an invaluable resource for researchers, professionals, and students seeking to explore innovative botanical therapies, making it a notable platform for disseminating high-quality research in this burgeoning field.